SCHEMBL7708586

SCHEMBL7708586

Nc1ncc(Cc2ccccc2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
HTT P42858 2/20 0.46
ROCK2 O75116 2/20 0.46
ROCK1 Q13464 2/20 0.46
ACHE P22303 1/20 0.45
DRD3 P35462 2/20 0.42
HTR2A P28223 1/20 0.42
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD5 P21918 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
METAP1 P53582 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714125 0.89 ROCK2 (0.47) KDM4EALDH1A1HTTROCK2ROCK1
SCHEMBL7714413 0.88 ROCK2 (0.44) ALDH1A1ROCK2ROCK1HTR2AMETAP1
SCHEMBL7712480 0.88 KMT2A (0.45) ROCK2ROCK1MEN1KMT2ASMN1; SMN2
SCHEMBL7714161 0.85 DHFR (0.44) ROCK2ROCK1MAPK1HRH4
SCHEMBL7712453 0.85 ROCK2 (0.42) ALDH1A1ROCK2ROCK1DRD3HTR2A
SCHEMBL7714603 0.85 HRH4 (0.57) HRH1HRH4
SCHEMBL7708553 0.81 DHFR (0.42) ALDH1A1HTTROCK2ROCK1SMN1; SMN2
SCHEMBL7714574 0.81 DHFR (0.41) ROCK2ROCK1MAPK1HRH4
SCHEMBL7714543 0.80 PIK3CA (0.55) ALDH1A1SMN1; SMN2TSHRMAPK1HSD17B10
SCHEMBL28839913 0.80 TAAR1 (0.53) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed